Company Overview and News

11
WABCO (WBC) Signs Contract to Supply Steering System in India

1h zacks
WABCO Holdings Inc. (WBC - Free Report) has signed a steering system deal in India with Tata Motors Limited (TTM - Free Report) , a global manufacturer of cars, utility vehicles, buses, trucks and defense vehicles. Per the deal, WABCO will supply its hydraulic power steering systems to meet Tata Motors’ performance and reliability requirements for manufacturing new heavy-duty trucks.
POOL WBC MGA OSK GTT MG 500570 TATAMOTORS TTM

5
Sensex falls 218 pts, Nifty below 11k as WPI inflation races to 4-yr high

1h freepressjournal.in
Mumbai: The benchmark BSE Sensex dropped by around 218 points or 0.60 per cent due to sell-off in banking, pharma, and metal stocks as investors turned cautious after wholesale inflation surged to a four-year high. The broad-based Nifty cracked below the 11,000-mark as 35 of its constituents closed in the red, led by Dr Reddy’s, Tata Steel and Lupin.
IBN HINDUNILVR BHRQY 533278 VEDL 532454 ICICIBANK 500470 TTST TATASTEEL TATLY HDB 532174 500180 500696 HDFCBANK 500570 BHARTIARTL TATAMOTORS CLNDY COALINDIA TTM

4
Ashok Leyland, Tata Motors slip 4-7% after reports of likely hike in truck, tractor trailer load capacity

4h moneycontrol
Commerical vehicle makers Ashok Leyland and Tata Motors dropped 6.8 percent and 4 percent respectively after reports of likely increase in load carrying capacity of trucks and tractor trailers.
500477 500570 AKLS TATAMOTORS AKLD TTM ASHOKLEY

4
Tata Harrier: 5 Hexa Mistakes To Avoid

5h freepressjournal.in
Make no mistake, the Tata Hexa is one of the best full-sized crossovers for its asking price. At Rs 12.49 lakh – 17.89 lakh (ex-showroom Delhi), it gives you a great mix of practicality, street cred, features and overall value. However, having driven the Hexa on many occasions, we’ve come across a few flaws in both product and packaging that should be avoided in the Tata Harrier.
500570 TATAMOTORS TTM

4
Ashok Leyland Q1 preview: Analysts see net profit rising threefold on surge in demand

7h moneycontrol
Gaining from a continued surge in demand across categories, and last year's lower base, domestic commercial vehicle manufacturer Ashok Leyland will likely post a threefold rise in its bottom line for the June quarter.
500477 500570 AKLS TATAMOTORS AKLD TTM ASHOKLEY

4
Sensex, Nifty turn choppy on weak Asian cues

7h freepressjournal.in
Mumbai: The BSE Sensex turned choppy after rising over 117 points in opening trade, amid weak Asian cues and foreign fund outflows. The broader Nifty, too, slipped below the 11,000-mark. The 30-share index fell 74.69 points, or 0.20 per cent, to 36,466.94 after touching a high of 36,558.71 in opening trade.
YESBANK AXB IBN 532648 YYBKY 533278 532215 AXBKY 500182 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 HEROMOTOCO HRTQY 500570 TATAMOTORS CLNDY COALINDIA TTM

4
Tata Motors slips 3% post Moody#39;s downgrades its rating

9h moneycontrol
Shares of Tata Motors declined more than 3 percent in the opening trade on Monday as Moody's has downgraded the corporate family rating of the company.
500570 TATAMOTORS TTM

4
Tata Motors, Mahindra top RD spenders in auto industry

19h moneycontrol
Homegrown companies Tata Motors and Mahindra & Mahindra were the biggest spenders on research and development in 2016-17 among 25 automakers in India which together invested Rs 6,344 crore, latest industry data showed.
BAJAJ-AUTO 532977 505200 CMQMY CUMMINSIND HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500033 ASHOKLEY ECQRY FORCEMOT MRZUY AKLD 532500 500182 500480 MARUTI 7269 501455 HRTQY GREAVESCOT AKLS TTM

4
This week in auto: Suzuki changes stance on electric vehicles in India, Tata Nano nears end of road

2018-07-14 moneycontrol
When the government first mooted the idea of going all-electric by 2030 in terms of mobility, there was widespread criticism and skepticism from all quarters of the automotive industry.
BAJAJ-AUTO TM 7269 7203 TYT 532977 500570 TOYOF TATAMOTORS TTM

4
Tata Motors Limited - Credit Rating

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500570 TATAMOTORS TTM

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

6h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...